P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation.
Shustik
C
C
Department of Medicine, McGill Cancer Center, Royal Victoria Hospital, Montreal, Quebec, Canada.
Dalton
W
W
Gros
P
P
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple / Q000235:genetics; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000235:genetics; D008099:Liver / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy / Q000235:genetics; D008969:Molecular Sequence Data; D009101:Multiple Myeloma / Q000188:drug therapy / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D004364:Pharmaceutical Preparations / Q000378:metabolism
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D004364:Pharmaceutical Preparations; D000251:Adenosine Triphosphatases